Patents
Recently, the U.S. Patent and Trademark Office (USPTO) issued updated guidance to agency employees on the proper application of obviousness doctrine when determining patent validity. As a representative of America’s inventor community who has strongly opposed certain developments at the USPTO, I want to express my gratitude to Director Vidal for her work in clarifying […]
On Tuesday, January 23, 2024, the Senate Judiciary’s IP Subcommittee held a hearing on the Patent Eligibility Restoration Act (PERA). The corporate lobbyists tell us that PERA will fix patent eligibility problems plaguing U.S. innovation for biotech, diagnostic methods, and inventions implemented in software. In his opening statement, Senator Tillis said, “We’ve said many […]
